Pharmacovigilance Market Size, Industry Share, Estimate And Future Growth To 2025 | Grand View Research, Inc
“The global pharmacovigilance market size was estimated at USD 4.31 billion in 2018 and is anticipated to witness a CAGR of 13.3% over the forecast period .�
The global pharmacovigilance market size is expected to reach USD 11.64 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 13.3% during the forecast period. Increasing incidence of Adverse Drug Reactions (ADR) is the key growth driver. The U.S. Food and Drug Administration (FDA) received approximately 253,017 serious adverse events and 44,693 deaths associated with ADRs in 2015. This shows the potential demand for implementing safety and Pharmacovigilance (PV) services. According to the World Health Organization’s (WHO) report on pharmaceuticals consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital set ups. Owing to this, there has been a significant rise in the number of medicines made available to healthcare consumers. Rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities. Major pharmaceutical companies are involved in extensive R&D initiatives for development of innovative therapeutic molecules. This has resulted in increased drug development activities. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period. Moreover, leading pharma companies in developed countries are focusing on outsourcing PV service in an attempt to reduce cost and to minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share. The companies operating in the pharmacovigilance market are undertaking strategic initiatives such as collaborations with the PV service providers to gain access to medical information and to manage PV workflows. For instance, In April 2017, Accenture entered in a collaborative agreement with BioCelebrate to develop a platform for aggregating
Follow Us:
and analyzing clinical information for improved drug developing efficiency, thus enhancing its R&D capabilities. These factors are anticipated to fuel the market growth.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/pharmacovigilance-industry Further key findings from the study suggest:
Phase IV held a dominant market share owing to the extensive post marketing surveillance of pharmaceuticals and increasing number of ADR incidences in the market
Phase III is anticipated to witness lucrative CAGR owing to increasing focus of pharmaceutical manufacturers on therapeutic development and safety monitoring
In service provider segment, contract outsourcing held a significant market share, owing to shift in focus of pharmaceutical companies to outsourcing services to reduce operational cost
Based on type of service, spontaneous reporting held the largest market share owing to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
Research organizations segment is anticipated to exhibit lucrative CAGR over the forecast period owing to increasing R&D for the development of novel biologics and medical devices
Asia Pacific pharmacovigilance market is anticipated to showcase lucrative CAGR in the forthcoming years
Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services.
Grand View Research has segmented the global pharmacovigilance market on the basis of the clinical trial phase, service provider, type of methods, end use, and region: Pharmacovigilance Clinical Trial Phase Outlook (Revenue, USD Million, 2014 - 2026) Pre-clinical
Phase I
Phase II
Phase III
Phase IV
Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2014 - 2026) In-house
Contract Outsourcing
Pharmacovigilance Type of Methods Outlook (Revenue, USD Million, 2014 - 2026) Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Follow Us:
Pharmacovigilance End Use Outlook (Revenue, USD Million, 2014 - 2026) Hospitals
Research Organizations
Industrial
Pharmacovigilance Regional Outlook (Revenue, USD Million, 2014 - 2026) North America
o
U.S.
o
Canada
Europe o
U.K.
o
Germany
o
Italy
o
Spain
o
Russia
Asia Pacific o
Japan
o
China
o
India
Latin America o
Brazil
o
Mexico
MEA o
South Africa
o
Saudi Arabia
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/healthcare-it Table of Content of Pharmacovigilance Market Chapter 1 Research Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates and Forecast Timeline 1.2 Research Methodology
Follow Us:
1.3 Information Procurement 1.3.1 Purchased database: 1.3.2 GVR’s Internal Database 1.3.3 Secondary sources 1.3.4 Primary Research: 1.3.5 Details of Primary Research 1.3.5.1 Data for primary interviews in North america 1.3.5.2 Data for primary interviews in Europe 1.3.5.3 Data for primary interviews in Asia Pacific 1.3.5.4 Data for primary interviews in Middle East and Africa 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.1.1 Approach 1: Commodity Flow Approach 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Report Objectives Chapter 2 Executive Summary 2.1 Market Outlook 2.1.1 Pharmacovigilance market Outlook, 2014 - 2026 (USD Million) 2.2 Segment Outlook 2.3 Competitive Outlook 2.4 Pharmacovigilance Market Summary, 2018 Chapter 3 Pharmacovigilance Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent market analysis 3.1.2 Ancillary market Analysis 3.2 Penetration & Growth Prospect Mapping 3.3 Technology Timeline Overview 3.3.1 Technology Timeline Pharmacovigilance changing technology & adoption
Follow Us:
3.4 Regulatory Framework 3.4.1 List of regulatory bodies 3.5 Pharmacovigilance Market Dynamics 3.5.1 Market driver analysis 3.5.1.1 Growing drug consumption and drug development rates 3.5.1.2 Increasing incidence of ADR and drug toxicity 3.5.1.3 Increasing trend of outsourcing pharmacovigilance services 3.5.2 Market restraint analysis 3.5.2.1 Lack of skilled labor 3.6 Pharmacovigilance Market Analysis Tools: Porters 3.6.1 Supplier Power 3.6.2 Buyer Power 3.6.3 Threat Of Substitutes 3.6.4 Threat Of New Entrants 3.6.5 Competitive Rivalary 3.7 PESTEL Analysis 3.7.1 Political Landscape 3.7.2 economic Landscape 3.7.3 technology Landscape 3.7.4 technology Landscape 3.7.5 social Landscape 3.8 Major Deals & Strategic Alliances Analysis 3.8.1 Mergers & Acquisitions 3.8.2 product launch 3.8.3 Expansion 3.8.4 Partnership & Collaborations 3.8.5 Market Entry Strategies Chapter 4 Pharmacovigilance Market: Competitive Analysis 4.1 Market Participation Categorization 4.2 Public Companies 4.2.1 Company market position analysis 4.2.2 Competitive Dashboard Analysis
Follow Us:
4.2.2.1 Market Differentiators 4.2.3 Company Market Share 4.2.4 Competitive Dashboard Analysis 4.3 Private Companies 4.3.1 List of key emerging companies Chapter 5 Pharmacovigilance Market: Product Estimates & Trend Analysis 5.1 Product Market Share Analysis, 2018 & 2026 5.2 Product Dashboard 5.2.1 Preclinical 5.2.1.1 Preclinical market estimates and forecasts, 2014 - 2026 (USD Million) 5.2.2 Phase I 5.2.2.1 Phase I market estimates and forecasts, 2014 - 2026 (USD Million) 5.2.3 Phase II 5.2.3.1 Phase II market estimates and forecasts, 2014 - 2026 (USD Million) 5.2.4 Phase III 5.2.4.1 Phase III market estimates and forecasts, 2014 - 2026 (USD Million) 5.2.5 Phase IV 5.2.5.1 Phase IV market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 6 Pharmacovigilance Market: Service provider Estimates & Trend Analysis 6.1 Service provider Market Share Analysis, 2018 & 2026 6.2 Service Provider Dashboard 6.3 In house 6.3.1 In house market estimates and forecasts, 2014 - 2026 (USD Million) 6.4 Contract outsourcing 6.4.1 Contract outsourcing market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 7 Pharmacovigilance Market: Type Estimates & Trend Analysis 7.1 Type Market Share Analysis, 2018 & 2026 7.2 Type Dashboard 7.3 Spontaneous Reporting 7.3.1 Spontaneous Reporting market estimates and forecasts, 2014 - 2026 (USD Million) 7.4 Intensified ADR Reporting 7.4.1 Intensified ADR Reporting market estimates and forecasts, 2014 - 2026 (USD Million)
Follow Us:
7.5 Targeted spontaneous reporting 7.5.1 Targeted spontaneous reporting market estimates and forecasts, 2014 - 2026 (USD Million) 7.6 Cohort Event Monitoring (CEM) 7.6.1 Cohort Event Monitoring (CEM) market estimates and forecasts, 2014 - 2026 (USD Million) 7.7 EHR Mining 7.7.1 EHR Mining market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 8 Pharmacovigilance Market: End Use Estimates & Trend Analysis 8.1 End Use Market Share Analysis, 2018 & 2026 8.2 End Use Dashboard 8.3 Hospitals 8.3.1 Hospitals market estimates and forecasts, 2014 - 2026 (USD Million) 8.4 Research organizations 8.4.1 Research organizations market estimates and forecasts, 2014 - 2026 (USD Million) 8.5 Industrial 8.5.1 Industrial market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 9 Pharmacovigilance Market: Regional Estimates & Trend Analysis, By, Product, Service Providers, Type, And End Use 9.1 Regional Market Snapshot 9.2 Market Share Analysis by Country, 2018 9.2.1 North America 9.2.2 Europe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 MEA 9.3 North America 9.3.1 North America Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.3.2 U.S. 9.3.2.1 U.S. Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.3.3 Canada 9.3.3.1 Canada Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.4 Europe 9.4.1 Europe Pharmacovigilance MARKET estimates and forecasts, 2014 - 2026 (USD Million)
Follow Us:
9.4.2 U.K. 9.4.2.1 U.K. Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.4.3 Germany 9.4.3.1 Germany Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.4.4 France 9.4.4.1 France Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.4.5 Italy 9.4.5.1 Italy Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.4.6 Russia 9.4.6.1 Russia Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.5 Asia Pacific 9.5.1 Asia Pacific Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.5.2 Japan 9.5.2.1 Japan Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.5.3 China 9.5.3.1 China Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.5.4 India 9.5.4.1 India Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.6 Latin America 9.6.1 Latin America Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.6.2 Mexico 9.6.2.1 Mexico Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.6.3 Brazil 9.6.3.1 Brazil Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.7 MEA 9.7.1 MEA Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.7.2 South Africa 9.7.2.1 South Africa Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) 9.7.3 Saudi Arabia 9.7.3.1 Saudi Arabia Pharmacovigilance market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 10 Company Profiles 10.1 Accenture
Follow Us:
10.1.1 Company overview 10.1.2 Financial performance 10.1.3 Product benchmarking 10.1.4 Strategic initiatives 10.2 Clinquest Group B.V. 10.2.1 Company overview 10.2.2 Product benchmarking 10.2.3 Strategic initiatives 10.3 Cognizant 10.3.1 Company overview 10.3.2 Financial Performance 10.3.3 Product benchmarking 10.3.4 Strategic initiatives 10.4 Laboratory Corporation of America Holdings 10.4.1 Company overview 10.4.2 Financial Performance 10.4.3 Product benchmarking 10.4.4 Strategic initiatives 10.5 IBM Corporation 10.5.1 Company overview 10.5.2 Product benchmarking 10.5.3 Strategic initiatives 10.6 ArisGlobal 10.6.1 Company overview 10.6.2 Financial Performance 10.6.3 Product benchmarking 10.6.4 Strategic initiatives 10.7 ICON Plc 10.7.1 Company overview 10.7.2 Product benchmarking 10.8 Capgemini 10.8.1 Company overview
Follow Us:
10.8.2 Financial Performance 10.8.3 Product benchmarking 10.8.4 Strategic initiatives 10.9 iMEDGlobal 10.9.1 Company overview 10.9.2 Financial performance 10.9.3 Product benchmarking 10.9.4 Strategic initiatives 10.10 ITClinical 10.10.1 Company overview 10.10.2 Financial performance 10.10.3 Product benchmarking 10.10.4 Strategic initiatives 10.11 Foresight Group International AG 10.11.1 Company overview 10.11.2 Financial performance 10.11.3 Product benchmarking 10.11.4 Strategic initiatives 10.12 TAKE Solutions 10.12.1 Company overview 10.12.2 Financial performance 10.12.3 Product benchmarking 10.12.4 Strategic initiatives 10.13 PAREXEL International Corporation 10.13.1 Company overview 10.13.2 Financial performance 10.13.3 Product benchmarking 10.13.4 Strategic initiatives 10.14 BioClinica, Inc. 10.14.1 Company overview 10.14.2 Financial performance 10.14.3 Product benchmarking
Follow Us:
10.14.4 Strategic initiatives 10.15 Wipro Limited 10.15.1 Company overview 10.15.2 Financial performance 10.15.3 Product benchmarking 10.15.4 Strategic initiatives 10.16 UNITED BIOSOURCE CORPORATION 10.16.1 Company overview 10.16.2 Financial performance 10.16.3 Product benchmarking 10.16.4 Strategic initiatives
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: